Odyssey Therapeutics, Inc.
SEC CIK 1882782 · ODTX · last insider filing 2026-05-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dimension Capital II, L.P. | Director | filed 2026 - 2026 |
| Smith IAN F | Director | filed 2026 - 2026 |
| Leiden Jeffrey M | Director | filed 2026 - 2026 |
| Walbert Timothy P | Director | filed 2026 - 2026 |
| Tatsis Ourania | Director | filed 2026 - 2026 |
| Odegard Valerie | Director | filed 2026 - 2026 |
| Chu Shelley | Director | filed 2026 - 2026 |
| Glick Gary D | Director · See Remarks | filed 2026 - 2026 |
| Li Nan (LN) | Director | filed 2026 - 2026 |
| Hill Paulina | Director | filed 2026 - 2026 |
| NG Carolyn | Director | filed 2026 - 2026 |
| Pavletic Aranicki Ksenija | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Haas Jason | Chief Financial Officer | filed 2026 - 2026 |
| Todd Collin M | See Remarks | filed 2026 - 2026 |
| Dales Natalie | See Remarks | filed 2026 - 2026 |
| Opipari Anthony W. | See Remarks | filed 2026 - 2026 |
| Siegel Jolie | See Remarks | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.